Drugs / Frozen Plasma
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00302965 | Apr 2005 → Dec 2006 | blood coagulation disease | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02561026 | Jan 2016 → Aug 2018 | blood coagulation disease | Ottawa Hospital Research Institute | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT04114643 Comparator | Sep 2019 → Jul 2020 | — | University Health Network, Toronto | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04534751 Comparator | Apr 2021 → Dec 2023 | blood coagulation disease | University Health Network, Toronto | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Frozen plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02561026 ↗ |
| Action | Restore | “coagulation factor replacement” NCT04114643 ↗ |